Dutch See First European Launch Of Clinuvel's Scenesse For Phototoxicity In EPP

Clinuvel is beginning the commercial launch in Europe of its orphan drug Scenesse for patients with erythropoietic protoporphyria, a rare condition that causes severe anaphylactic reactions and burns when the skin is exposed to sunlight.